Transition from first illicit drug use to first injection drug use among rural Appalachian drug users: a cross‐sectional comparison and retrospective survival analysis
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Aim The study's objectives were to characterize initiation of injection drug use, examine the independent association of specific substance use with injection drug use and determine factors associated with rates of transition from first illicit drug use to first injection among a sample of rural Appalachian drug users. Design Interview‐administered questionnaires were administered to a sample of drug users recruited via respondent‐driven sampling. Setting Appalachian Kentucky. Participants Injection drug users (IDUs) (n = 394) and non‐IDUs (n = 109). Measurements Data were collected on substance use and years from age at initiation of illicit substance use to ‘event’ (initiation of injection or date of baseline interview for non‐IDUs). Logistic regression and Cox regression were used to identify factors associated with life‐time injection drug use and transition time to injection, respectively. Findings OxyContin® was involved in nearly as many initiations to injection (48%), as were stimulants, other prescription opioids and heroin combined; for participants who initiated with OxyContin®, the median time from which they began OxyContin® use to their first injection of OxyContin® was 3 years. Adjusting for demographics, five prescription drugs (benzodiazepines, illicit methadone, oxycodone, OxyContin® and other opiates) were associated with an increased hazard for transitioning from first illicit drug use to first injection drug use (each at P < 0.01). Conclusions In Appalachia, in the United States, the prescription opioid OxyContin® is widely used non‐medically and appears to show a particularly high risk of rapid transition to injection compared with the use of other illicit drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Modeling Survival Data: Extending the Cox Model
Therneau, T. M., & Grambsch, P. M. (2000) · Statistics for Biology and Health · doi:10.1007/978-1-4757-3294-8 · Cited by 8,674
Illicit use of opioids: is OxyContin a “gateway drug”?
Grau, L. E., Dasgupta, N., Harvey, A. P., Irwin, K., Givens, A., Kinzly, M. L., & Heimer, R. (2007) · The American Journal on Addictions · doi:10.1080/10550490701375293 · Cited by 177 · cited 3×
“The authors concluded that polyopioid use may serve as a “gateway” behavior that places individuals at higher risk for a quicker transition to heroin and/or injection drug use [53].”
BackgroundMethodNonmedical Prescription Drug Use Among Adolescents: The Influence of Bonds to Family and School
Ford, J. A. (2009) · Youth & Society · doi:10.1177/0044118x08316345 · Cited by 140 · cited 1×
“However, research suggests that communities’ profile of drug use may differ in rural settings [33-40], specifically routes of administration [33].”
Background
Cited by
Keyes, K. M., Cerdá, M., Brady, J. E., Havens, J. R., & Galea, S. (2014) · American Journal of Public Health · doi:10.2105/ajph.2013.301709 · Cited by 580
Self-citationJones, C. M. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2013.01.007 · Cited by 517
The epidemiology of benzodiazepine misuse: A systematic review*
Votaw, V. R., Geyer, R., Rieselbach, M. M., & McHugh, R. K. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.02.033 · Cited by 479
“Every ‘Never’ I Ever Said Came True”: Transitions from opioid pills to heroin injecting
Mars, S. G., Bourgois, P., Karandinos, G., Montero, F., & Ciccarone, D. (2014) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2013.10.004 · Cited by 432
Fiellin, D. A., Schottenfeld, R. S., Cutter, C. J., Moore, B. A., Barry, D. T., & O’Connor, P. G. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.5302 · Cited by 184
Metadata
- Authors
- Young, A. M., & Havens, J. R.
- Venue
- Addiction
- Publisher
- Wiley
- Published
- 2011-10-26
- Volume
- 107
- Issue
- 3
- Pages
- 587-596
- ISSN
- 0965-2140 (ISSN-L)
- 1360-0443
- OpenAlex
- W2152187555
- Cited by
- 143
- References
- 3
- FWCI
- 7.35
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.